The First Take – Pfizer makes migraine move

FirstTake on Pharma - Pharma News and Analysis Podcast

English - November 12, 2021 14:00 - 13 minutes - 9.04 MB - ★★★★★ - 2 ratings
Science pharma pharmaceutical intelligence firstword firsttake cardiovascular dermatology diabetes immunology infectious diseases Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: The First Take – Novartis sells Roche stake for big bucks

Next Episode: The First Take – Pfizer’s antiviral haul, BMS lays out a growth strategy and Biogen’s week to forget

FirstWord Pharma PLUS editors Virginia Li, Michael Flanagan and Simon King discuss impressive data for Pfizer’s COVID-19 antiviral drug, its deal this week to partner up with migraine specialist Biohaven Pharmaceuticals, what the future holds for GlaxoSmithKline’s renal anaemia drug daprodustat and Zai Lab’s move into the neuroscience field.